All Stories

  1. Stromal vascular fraction technologies and clinical applications
  2. A contemporary view of platelet-rich plasma therapies: moving toward refined clinical protocols and precise indications
  3. Adult Cells Combined With Platelet-Rich Plasma for Tendon Healing
  4. Clinical benefits and drawbacks of local corticosteroids injections in tendinopathies
  5. Biological Therapies in Regenerative Sports Medicine
  6. The Properties of 3 Different Plasma Formulations and Their Effects on Tendinopathic Cells
  7. Clinical Outcomes of Biologic Treatment for Chronic Tendinopathy
  8. Biological approach for the management of non-healing diabetic foot ulcers
  9. Potential Links Between Tendon Pathology and Platelet Rich Plasma Biology
  10. Hyperuricemia in Tendons
  11. How Obesity Affects Tendons?
  12. Tendons Involvement in Congenital Metabolic Disorders
  13. Three-Dimensional Platelet-Rich Plasma Hydrogel Model to Study Early Tendon Healing
  14. The Conservative Management of Osteoarthritis — Hyaluronic Acid, Platelet Rich Plasma or the Combination?
  15. Muscle and Tendon Injuries: The Role of Biological Interventions to Promote and Assist Healing and Recovery
  16. Platelet-rich plasma in the treatment of skeletal muscle injuries
  17. Meeting current musculoskeletal health demand through deeper insights into tissue homeostasis and regeneration
  18. Platelet-rich Plasma Modulates the Secretion of Inflammatory/Angiogenic Proteins by Inflamed Tenocytes
  19. Efficacy and safety of autologous platelet rich plasma for the treatment of vascular ulcers in primary care: Phase III study
  20. Use of Platelet-Rich Plasma for Patellar Tendon and Medial Collateral Ligament Injuries: Best Current Clinical Practice
  21. Anti-inflammatory and Matrix Restorative Mechanisms of Platelet-Rich Plasma in Osteoarthritis: Letter to the Editor
  22. Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association?
  23. Editorial
  24. Angiogenic and innate responses triggered by PRP in tendon cells are not modified by hyperuricemia
  25. Hyperuricemic PRP in Tendon Cells
  26. Platelet-rich Plasma for Muscle Injury and Tendinopathy
  27. Platelet-rich plasma for managing pain and inflammation in osteoarthritis
  28. Platelet-rich plasma: underlying biology and clinical correlates
  29. Management of limited joint mobility in diabetic patients
  30. Occurrence of tendon pathologies in metabolic disorders
  31. Revisiting Physical Examination: Abadie's Sign and Achilles Intratendinous Changes in Subjects with Diabetes
  32. Platelet-rich plasma (PRP) in chronic epicondylitis: study protocol for a randomized controlled trial
  33. Platelet-rich plasma injections for tendinopathy and osteoarthritis
  34. Biological Approach to Anterior Cruciate Ligament Surgery
  35. Platelet-Rich Plasma in Muscle and Tendon Healing
  36. Basic Science: Molecular and Biological Aspects of Platelet-Rich Plasma Therapies
  37. Platelet Rich Plasma (PRP) Biotechnology: Concepts and Therapeutic Applications in Orthopedics and Sports Medicine
  38. Joint pathology and platelet-rich plasma therapies
  39. Arthroscopic management and platelet-rich plasma therapy for avascular necrosis of the hip
  40. Platelet rich plasma therapies for sports muscle injuries: any evidence behind clinical practice?
  41. Autologous Platelet-Rich Plasma: A Revolution in Soft Tissue Sports Injury Management?
  42. Tendon healing and platelet-rich plasma therapies
  43. Poor Standardization in Platelet-Rich Therapies Hampers Advancement
  44. Ligamentization of Tendon Grafts Treated With an Endogenous Preparation Rich in Growth Factors: Gross Morphology and Histology
  45. The Future: Optimizing the Healing Environment in Anterior Cruciate Ligament Reconstruction
  46. The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: A histologic and histomorphometric study
  47. Shedding light in the controversial terminology for platelet rich products
  48. Nonunions Treated With Autologous Preparation Rich in Growth Factors
  49. Platelet-Rich Therapies in the Treatment of Orthopaedic Sport Injuries
  50. Management of post-surgical Achilles tendon complications with a preparation rich in growth factors: A study of two-cases
  51. Relationship between Investigative Biomarkers and Radiographic Grading in Patients with Knee Osteoarthritis
  52. 5-year clinical experience with BTI®dental implants: risk factors for implant failure
  53. Clinical Outcome of Immediately Loaded Dental Implants Bioactivated With Plasma Rich in Growth Factors: A 5-Year Retrospective Study
  54. Delivering growth factors for therapeutics
  55. Five-Year Clinical Evaluation of Short Dental Implants Placed in Posterior Areas: A Retrospective Study
  56. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers
  57. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields☆
  58. Reciprocal Actions of Platelet-Secreted TGF-??1 on the Production of VEGF and HGF by Human Tendon Cells
  59. New insights into and novel applications for platelet-rich fibrin therapies
  60. Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities
  61. Autologous platelets as a source of proteins for healing and tissue regeneration
  62. Differential Effect of Haloperidol and Clozapine on Plasma Homovanillic Acid in Elderly Schizophrenic Patients with or without Tardive Dyskinesia
  63. Plasma prolactin and plasma homovanillic acid: Predictors of clinical response in schizophrenia
  64. Schizophrenia: Gender, family risk, and plasma homovanillic acid
  65. Chronic neuroleptic treatment does not suppress the dynamic characteristics of the dopaminergic receptor D2 system
  66. Morning variations of plasma homovanillic acid in untreated schizophrenic patients